Patent · US Active

Bicyclic heteroaromatic compounds

US9249140B2 · kind B2 · utility

5Cited by
8References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 26, 2012
Grant dateFeb 2, 2016
Priority date
Expiry dateJul 26, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the formula I, in which X1, X2, X3, X4, X5, R1, R2, R3, R4, R5 and R6 have the meanings indicated in Claim 1, are kinase inhibitors and can be employed, inter alia, for the treatment of tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.